PROFOUND MED CORP's ticker is PROF and the CUSIP is 74319B502. A total of 38 filers reported holding PROFOUND MED CORP in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $690,856 | -15.2% | 67,731 | +8.2% | 0.00% | 0.0% |
| Q2 2023 | $814,504 | +49.5% | 62,606 | +6.7% | 0.00% | – |
| Q1 2023 | $544,961 | -46.4% | 58,661 | -37.2% | 0.00% | -100.0% |
| Q4 2022 | $1,016,603 | +360.0% | 93,352 | +70.9% | 0.00% | – |
| Q3 2022 | $221,000 | -50.7% | 54,611 | -11.2% | 0.00% | – |
| Q2 2022 | $448,000 | -17.9% | 61,481 | +1.4% | 0.00% | – |
| Q1 2022 | $546,000 | -34.5% | 60,646 | -18.0% | 0.00% | -100.0% |
| Q4 2021 | $834,000 | -12.9% | 73,927 | +12.5% | 0.00% | 0.0% |
| Q3 2021 | $958,000 | +7.9% | 65,696 | +20.4% | 0.00% | 0.0% |
| Q2 2021 | $888,000 | +24.7% | 54,560 | +53.7% | 0.00% | 0.0% |
| Q1 2021 | $712,000 | +61.5% | 35,506 | +65.6% | 0.00% | – |
| Q4 2020 | $441,000 | +7.0% | 21,440 | -8.5% | 0.00% | -100.0% |
| Q3 2020 | $412,000 | +312.0% | 23,421 | +125.2% | 0.00% | – |
| Q1 2020 | $100,000 | – | 10,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timelo Investment Management Inc. | 673,158 | $6,866,212 | 9.03% |
| Gagnon Advisors, LLC | 679,296 | $6,928,819 | 5.80% |
| GAGNON SECURITIES LLC | 1,582,166 | $16,138,093 | 4.04% |
| THOMPSON DAVIS & CO., INC. | 86,375 | $881,025 | 1.09% |
| LETKO, BROSSEAU & ASSOCIATES INC | 1,164,125 | $11,352,296 | 0.22% |
| Zweig-DiMenna Associates LLC | 87,274 | $890,195 | 0.10% |
| MTM Investment Management, LLC | 19,875 | $202,725 | 0.10% |
| ROYCE & ASSOCIATES LP | 569,898 | $5,714,714 | 0.06% |
| Harbor Advisors LLC | 12,400 | $126,480 | 0.03% |
| FIL Ltd | 1,200,635 | $12,039,498 | 0.01% |